ArticleThe Journal of antimicrobial chemotherapy2025

A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma.

Jingyi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.